Status Epilepticus: Multimedia

References

1. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia. Jun 1970;11(2):187-97. [Medline].

2. Aicardi J, Chevrie JJ. Consequences of status epilepticus in infants and children. Adv Neurol. 1983;34:115-25. [Medline].

3. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. Nov 1980;69(5):657-66. [Medline].

4. Barry E, Hauser WA. Status epilepticus: the interaction of epilepsy and acute brain disease. Neurology. Aug 1993;43(8):1473-8. [Medline].

5. Barry E, Hauser WA. Pleocytosis after status epilepticus. Arch Neurol. Feb 1994;51(2):190-3. [Medline].

6. Berkovic SF, Andermann F, Guberman A, et al. Valproate prevents the recurrence of absence status. Neurology. Oct 1989;39(10):1294-7. [Medline].

7. Berkovic SF, Bladin PF. Absence status in adults. Clin Exp Neurol. 1983;19:198-207. [Medline].

8. Boggs JG, Marmarou A, Agnew JP, et al. Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res. Aug 1998;31(3):199-209. [Medline].

9. Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. J Clin Neurophysiol. Sep-Oct 2004;21(5):319-31. [Medline].

10. Cascino GD. Nonconvulsive status epilepticus in adults and children. Epilepsia. 1993;34 Suppl 1:S21-8. [Medline].

11. Cascino GD, Hesdorffer D, Logroscino G, Hauser WA. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia. Aug 1998;39(8):829-32. [Medline].

12. Celesia GG. Modern concepts of status epilepticus. JAMA. Apr 12 1976;235(15):1571-4. [Medline].

13. Christensen RC, Szlabowicz JW. Factitious status epilepticus as a particular form of Munchausen's syndrome. Neurology. Dec 1991;41(12):2009-10. [Medline].

14. D'Giano CH, Del C Garcia M, Pomata H, Rabinowicz AL. Treatment of refractory partial status epilepticus with multiple subpial transection: case report. Seizure. Jul 2001;10(5):382-5. [Medline].

15. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. Apr 1996;46(4):1029-35. [Medline].

16. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. Jul 1995;12(4):316-25. [Medline].

17. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33 Suppl 4:S15-25. [Medline].

18. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. Aug 1998;39(8):833-40. [Medline].

19. Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Status epilepticus: summary. Adv Neurol. 1983;34:537-41. [Medline].

20. Doose H, Volzke E. Petit mal status in early childhood and dementia. Neuropadiatrie. Feb 1979;10(1):10-4. [Medline].

21. Duane DC, Ng YT, Rekate HL, et al. Treatment of refractory status epilepticus with hemispherectomy. Epilepsia. Aug 2004;45(8):1001-4. [Medline].

22. Epilepsy Foundation of America. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. Aug 18 1993;270(7):854-9. [Medline].

23. Fischer JH, Raineri DL. Pentobarbital anesthesia for status epilepticus. Clin Pharm. Aug 1987;6(8):601-2. [Medline].

24. Granner MA, Lee SI. Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia. Jan-Feb 1994;35(1):42-7. [Medline].

25. Guberman A, Cantu-Reyna G, Stuss D, Broughton R. Nonconvulsive generalized status epilepticus: clinical features, neuropsychological testing, and long-term follow-up. Neurology. Oct 1986;36(10):1284-91. [Medline].

26. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology. May 1990;40(5 Suppl 2):9-13. [Medline].

27. Janz D. Conditions and causes of status epilepticus. Epilepsia. Jun 1961;2:170-7. [Medline].

28. Kaplan PW. The EEG of status epilepticus. J Clin Neurophysiol. Jun 2006;23(3):221-9. [Medline].

29. Lennox W, Lennow MA. Epilepsy and Related Disorders. Boston, MA: Little Brown;. 1960.

30. Leppik IE, Boucher BA, Wilder BJ, et al. Pharmacokinetics and safety of a phenytoin prodrug given i.v. or i.m. in patients. Neurology. Mar 1990;40(3 Pt 1):456-60. [Medline].

31. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. May 1990;40(5 Suppl 2):13-23. [Medline].

32. Lowenstein DH. Treatment options for status epilepticus. Curr Opin Pharmacol. Feb 2003;3(1):6-11. [Medline].

33. Lüders HO, Rona S, Rosenow F, et al. A semiological classification of status epilepticus. Epileptic Disord. Jun 2005;7(2):149-50. [Medline].

34. Ma X, Liporace J, O'Connor MJ, Sperling MR. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res. Jul 2001;46(1):33-8. [Medline].

35. Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. Jan 1973;28(1):1-9. [Medline].

36. Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. Adv Neurol. 1983;34:261-75. [Medline].

37. Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. Aug 1973;29(2):82-7. [Medline].

38. Meldrum BS. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. Oct 1993;3(4):405-12. [Medline].

39. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. Aug 24 2005;25(34):7724-33. [Medline].

40. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. Aug 2005;25(34):7724-33.

41. Pakalnis A, Drake ME, Phillips B. Neuropsychiatric aspects of psychogenic status epilepticus. Neurology. Jul 1991;41(7):1104-6. [Medline].

42. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology. Oct 1994;44(10):1837-40. [Medline].

43. Parviainen I, Uusaro A, Kalviainen R, et al. Propofol in the treatment of refractory status epilepticus. Intensive Care Med. Jul 2006;32(7):1075-9. [Medline].

44. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. Nov 2005;62(11):1698-702. [Medline].

45. Shinnar S, Pellock JM, Moshe SL, et al. In whom does status epilepticus occur: age-related differences in children. Epilepsia. Aug 1997;38(8):907-14. [Medline].

46. Shorvon S. The outcome of tonic-clonic status epilepticus. Curr Opin Neurol. Apr 1994;7(2):93-5. [Medline].

47. Siesjo BK, Ingvar M, Folbergrova J, Chapman AG. Local cerebral circulation and metabolism in bicuculline-induced status epilepticus: relevance for development of cell damage. Adv Neurol. 1983;34:217-30. [Medline].

48. Simon RP. Physiologic consequences of status epilepticus. Epilepsia. 1985;26 Suppl 1:S58-66. [Medline].

49. Sirven JI, Zimmerman RS, Carter JL, et al. MRI changes in status epilepticus. Neurology. Jun 10 2003;60(11):1866. [Medline].

50. Soffer D, Melamed E, Assaf Y, Cotev S. Hemispheric brain damage in unilateral status epilepticus. Ann Neurol. Dec 1986;20(6):737-40. [Medline].

51. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. Jan 1998;39(1):18-26. [Medline].

52. Thomas P, Beaumanoir A, Genton P, et al. 'De novo' absence status of late onset: report of 11 cases. Neurology. Jan 1992;42(1):104-10. [Medline].

53. Tomson T, Svanborg E, Wedlund JE. Nonconvulsive status epilepticus: high incidence of complex partial status. Epilepsia. May-Jun 1986;27(3):276-85. [Medline].

54. Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia. Sep-Oct 1992;33(5):829-35. [Medline].

55. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. Jan-Feb 1994;35(1):27-34. [Medline].

56. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. Jan-Feb 1990;5(1):49-60. [Medline].

57. Treiman DM, Meyers PD, Walton NY. DVA Status Epilepticus Cooperative Study Group. Duration of generalized convulsive status epilepticus: relationship to clinical symptomatology and response to treatment. Epilepsia. 1992;33(Suppl 3):66.

58. Treiman DM, Meyers PD, Walton NY. DVA Status Epilepticus Cooperative Study Group. Factors that predict prognosis in generalized convulsive status epilepticus. Epilepsia. 1993;34(Suppl 6):30.

59. Treiman DM. Generalized convulsive, nonconvulsive, and focal status epilepticus. In: Feldman E, ed. Current Diagnosis in Neurology. St. Louis: Mosby-Year Book;1994:11-8.

60. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol. Jul 1995;12(4):343-62. [Medline].

61. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. Sep 17 1998;339(12):792-8. [Medline].

62. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging. 2001;18(2):133-42. [Medline].

63. White PT, Grant P, Mosier J, Craig A. Changes in cerebral dynamics associated with seizures. Neurology. Apr 1961;11(4)Pt 1:354-61. [Medline].

64. Wieshmann UC, Woermann FG, Lemieux L, et al. Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia. Nov 1997;38(11):1238-41. [Medline].

65. Wilson JV, Reynolds EH. Texts and documents. Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy. Med Hist. Apr 1990;34(2):185-98. [Medline].

66. Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg. Apr 2001;34(4):190-2. [Medline].

Further Reading

Keywords

SE, absence status epilepticus, complex partial status epilepticus, generalized convulsive status epilepticus, nonconvulsive status epilepticus, simple partial status epilepticus, subtle status epilepticus, Treiman's classification, nonepileptic seizures, NES

Contributor Information and Disclosures

Author

Mark Spitz, MD, Professor, Department of Neurology, University of Colorado Health Sciences Center
Mark Spitz, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, and American Epilepsy Society
Disclosure: abbott Consulting fee Independent contractor

Coauthor(s)

Frank Lum, MD, Instructor, Department of Neurology, University of Colorado Health Sciences Center
Disclosure: Nothing to disclose.

Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio
Jose E Cavazos, MD, PhD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and Society for Neuroscience
Disclosure: Glaxo-SmithKline Honoraria Speaking and teaching; Ortho-McNeil Neurologics Honoraria Speaking and teaching; UCB Pharma Honoraria Speaking and teaching

Edward Maa, MD, Epilepsy Fellow, Department of Neurology, University of Colorado Health Science Center
Disclosure: Nothing to disclose.

Medical Editor

Joseph F Hulihan, MD, Vice President, Medical Affairs, Ortho-McNeil Janssen Scientific Affairs, LLC
Joseph F Hulihan, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, American Headache Society, and American Medical Association
Disclosure: Johnson & Johnson Salary Employment; Johnson & Johnson Stock Employment

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Norberto Alvarez, MD, Assistant Professor, Department of Neurology, Harvard Medical School; Consulting Staff, Department of Neurology, Boston Children's Hospital
Norberto Alvarez, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, and Child Neurology Society
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.